AI assistant
Sending…
SHOULDER INNOVATIONS, INC. — Director's Dealing 2026
Mar 17, 2026
33484_dirs_2026-03-17_32f32826-fb01-428c-9828-fde1dc251e96.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SHOULDER INNOVATIONS, INC. (SI)
CIK: 0001699350
Period of Report: 2026-03-13
Reporting Person: BUCKMAN PAUL (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-03-13 | Common Stock | M | 19401 | $2.4804 | Acquired | 39505 | Direct |
| 2026-03-13 | Common Stock | M | 26205 | $2.0988 | Acquired | 65710 | Direct |
| 2026-03-13 | Common Stock | F | 3292 | $14.62 | Disposed | 62418 | Direct |
| 2026-03-13 | Common Stock | F | 3714 | $14.82 | Disposed | 58704 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2026-03-13 | Stock Option | $2.4804 | M | 19401 | Disposed | 2033-05-17 | Common Stock (19401) | Direct |
| 2026-03-13 | Stock Option | $2.0988 | M | 26205 | Disposed | 2030-12-16 | Common Stock (26205) | Direct |
Footnotes
F1: Includes the following shares received without consideration as in-kind distributions: (i) 3,144 shares from cultivate(MD) Capital Accelerator Fund, L.P.; and (ii) 3,096 shares from Cultivate MD Capital Fund II, LP. In prior reports, the reporting person reported beneficial ownership of 13,864 shares of Shoulder Innovations common stock held directly.
F2: The stock option vests in 36 equal monthly increments beginning on June 30, 2023.
F3: The stock option is fully vested and currently exercisable.
More from SHOULDER INNOVATIONS, INC.
Annual Report
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 29
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 14
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Director's Dealing
2026
Mar 17
Board/Management Information
2026
Mar 2
Director's Dealing
2026
Feb 10
Director's Dealing
2026
Feb 3